NYSE:CHEHealthcare
Assessing Chemed (CHE) Valuation After A Difficult Year For Shareholders
Recent performance context for Chemed
Chemed (CHE) has drawn fresh attention after a challenging year for the stock, with negative total returns over the past year and past 3 months prompting investors to reassess the business and its current valuation.
See our latest analysis for Chemed.
With the share price at $377.57, Chemed’s recent 10.4% 1 month share price decline and 11.75% 3 month share price decline sit alongside a 38.27% 1 year total shareholder return decline. This suggests...